No registrations found.
ID
Source
Brief title
Health condition
HIV, hemodialysis, bonemarrow transplant, reumatologic patients, lung transplant patients.
Sponsors and support
Intervention
Outcome measures
Primary outcome
GMT 30 days post vaccination.
Secondary outcome
Protection rates.
Background summary
Intradermal vs intramuscular influenza vaccination in different groups with cellular immunodeficiencies. Intradermal vaccination might lead to better responses.
Study objective
Intradermal vaccination with one fith of the total vacine dose intradermally is just as efficient as intramuscular vaccination with the regular dose.
Study design
N/A
Intervention
1. Intradermal vaccination;
2. Intramuscular vaccination.
P.O. Box 9600
L.B.S. Gelinck
Leiden 2300 RC
The Netherlands
+31 (0)71 5269111
L.B.S.Gelinck@LUMC.nl
P.O. Box 9600
L.B.S. Gelinck
Leiden 2300 RC
The Netherlands
+31 (0)71 5269111
L.B.S.Gelinck@LUMC.nl
Inclusion criteria
Immunocompromized patients at least 18 years of age.
Exclusion criteria
1. Active infection;
2. Pregnancy;
3. Life expectancy of less than 6 months;
4. Thrombocetopenia;
5. Coumarin therapy;
6. Thinskin with steroids;
7. Known allergies;
8. Influenza vaccination within last 9 months.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL235 |
| NTR-old | NTR273 |
| Other | : p05.115 |
| ISRCTN | ISRCTN15762138 |